Ligand Pharmaceuticals, Inc. <LGND.O>: Oppenheimer Raises Target Price to $326 From $285
LGND•Related News
DoubleLine Yield Opportunities Fund declares August distribution of $0.12 a share
DLY•
Ukraine's attacks on Russian energy sites — what has been hit?
XLE•
Emerson Electric announces DeltaV Automation Platform for AI-scale data centers
EMR•
Cyabra wins multi-year, six-figure contract with APAC intelligence agency
CYAB•
Nasdaq trade halt continues <QMMM.O> reason not available at 09:05 am
QMMM•